Active, Not Recruiting
A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin Melanoma
NCT05751928
- Conditions
- Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Melanoma (Skin), +12 more
- Locations
-
- State Institution "Republican Scientific and Practical Center of Oncology and Medical Radiology named after A.I. N.N. Alexandrov" Lesnoy, Belarus
- Healthcare Institution "Minsk City Clinical Cancer Center" Minsk, Belarus
- State Institution "Mogilev Regional Oncological Dispensary" Mogilev, Belarus
- Healthcare Institution "Vitebsk Regional Clinical Oncology Center" Vitebsk, Belarus